We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFGC icon
2276
Performance Food Group
PFGC
$16.4B
$731K ﹤0.01%
22,656
-932
-4% -$29.6K
CEO
2277
DELISTED
CNOOC Limited
CEO
$730K ﹤0.01%
4,791
+1,616
+51% +$275K
NATI
2278
DELISTED
National Instruments Corp
NATI
$729K ﹤0.01%
16,059
-6,406
-29% -$299K
FBND icon
2279
Fidelity Total Bond ETF
FBND
$27.4B
$728K ﹤0.01%
14,994
-3,028
-17% -$146K
GURU icon
2280
Global X Guru Index ETF
GURU
$64.2M
$728K ﹤0.01%
26,368
-743
-3% -$22.2K
TAK icon
2281
Takeda Pharmaceutical
TAK
$55.5B
$727K ﹤0.01%
+43,193
New +$729K
ASH icon
2282
Ashland
ASH
$3.36B
$726K ﹤0.01%
10,226
-765
-7% -$59K
DINT icon
2283
Davis Select International ETF
DINT
$291M
$726K ﹤0.01%
+48,163
New +$779K
RFG icon
2284
Invesco S&P MidCap 400 Pure Growth ETF
RFG
$361M
$726K ﹤0.01%
27,575
-22,020
-44% -$645K
RGNX icon
2285
Regenxbio
RGNX
$704M
$725K ﹤0.01%
17,288
-950
-5% -$55.7K
PAGS icon
2286
PagSeguro Digital
PAGS
$2.43B
$724K ﹤0.01%
38,675
+22,013
+132% +$540K
MCHX icon
2287
Marchex
MCHX
$80.6M
$723K ﹤0.01%
272,729
-2,526
-0.9% -$7.11K
BH icon
2288
Biglari Holdings Class B
BH
$1.22B
$721K ﹤0.01%
6,346
-4,859
-43% -$717K
AMU
2289
DELISTED
ETRACS Alerian MLP Index ETN
AMU
$721K ﹤0.01%
51,508
-39,662
-44% -$631K
IBOC icon
2290
International Bancshares
IBOC
$4.57B
$715K ﹤0.01%
20,778
ACSI icon
2291
American Customer Satisfaction ETF
ACSI
$119M
$714K ﹤0.01%
24,725
-44,478
-64% -$1.42M
AGGP
2292
DELISTED
IQ Enhanced Core Plus Bond U.S. ETF
AGGP
$712K ﹤0.01%
37,641
-397,588
-91% -$7.51M
NWS icon
2293
News Corp Class B
NWS
$17.8B
$711K ﹤0.01%
61,535
-8,000
-12% -$105K
NTUS
2294
DELISTED
Natus Medical Inc
NTUS
$711K ﹤0.01%
20,888
-1,165
-5% -$37.9K
RA
2295
Brookfield Real Assets Income Fund
RA
$704M
$710K ﹤0.01%
37,255
-11,290
-23% -$235K
FFBC icon
2296
First Financial Bancorp
FFBC
$3.6B
$708K ﹤0.01%
29,840
+1,741
+6% +$46K
MINI
2297
DELISTED
Mobile Mini Inc
MINI
$705K ﹤0.01%
22,191
-17,734
-44% -$687K
TGNA
2298
DELISTED
TEGNA Inc
TGNA
$698K ﹤0.01%
64,194
-3,467
-5% -$41.8K
EQC
2299
DELISTED
Equity Commonwealth
EQC
$698K ﹤0.01%
23,258
+2,824
+14% +$86K
PSK icon
2300
State Street SPDR ICE Preferred Securities ETF
PSK
$685M
$696K ﹤0.01%
17,588
-21,225
-55% -$864K

Similar funds

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.